Omeros Raises $68.2M in Washingtons First IPO in Two Years
Summary
Omeros Raises $68.2M in Washington’s First IPO in Two Years Xconomy Seattle — Omeros, the Seattle biotech company developing a treatment to improve recovery from knee surgery, completed its initial public offering late last night in the state’s first IPO in more than two years.The underwriters of the offering, led by Deutsche Bank and Wedbush PacGrow Life Sciences, will have options to buy an additional 1.02 million shares.Omeros is the first tech company from Washington state to go public since Kirkland, WA-based Clearwire (NASDAQ: CLWR) did it in March 2007.But without that money, Omeros would have needed to “significantly modify our operational plans for us to continue as a going concern,” the company stated.The company is facing a lawsuit from former chief financial officer Richard J. Klein, who accused Omeros of wrongfully terminating him.